Title | Type | SJR | H index | Total Docs. (2007) | Total Docs. (3years) | Total Refs. (2007) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2007) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Nature Reviews Drug Discovery | journal | 7.774 Q1 | 391 | 158 | 818 | 7071 | 5391 | 294 | 7.07 | 44.75 | |
2 | Reviews of Physiology Biochemistry and Pharmacology | journal | 4.568 Q1 | 70 | 7 | 32 | 1963 | 222 | 32 | 5.78 | 280.43 | |
3 | Trends in Pharmacological Sciences | journal | 4.509 Q1 | 244 | 91 | 327 | 5036 | 3137 | 302 | 9.20 | 55.34 | |
4 | Cellular and Molecular Life Sciences | journal | 3.265 Q1 | 261 | 275 | 804 | 25263 | 4711 | 800 | 5.76 | 91.87 | |
5 | Neuropsychopharmacology | journal | 3.143 Q1 | 249 | 247 | 773 | 15129 | 5007 | 741 | 6.00 | 61.25 | |
6 | Current Opinion in Pharmacology | journal | 3.033 Q1 | 148 | 98 | 298 | 4669 | 2072 | 266 | 6.62 | 47.64 | |
7 | Neurotherapeutics | journal | 2.567 Q1 | 136 | 80 | 162 | 5502 | 1103 | 146 | 6.15 | 68.78 | |
8 | Controlled Clinical Trials | journal | 2.100 Q1 | 76 | 0 | 47 | 0 | 210 | 40 | 0.00 | 0.00 | |
9 | Psychopharmacology | journal | 2.029 Q1 | 214 | 360 | 1197 | 20492 | 5355 | 1151 | 4.20 | 56.92 | |
10 | Neuropharmacology | journal | 1.935 Q1 | 191 | 275 | 740 | 13822 | 3089 | 737 | 3.45 | 50.26 | |
11 | Drug and Alcohol Dependence | journal | 1.849 Q1 | 187 | 265 | 518 | 11726 | 2095 | 507 | 3.66 | 44.25 | |
12 | International Journal of Neuropsychopharmacology | journal | 1.818 Q1 | 125 | 90 | 238 | 4110 | 910 | 201 | 3.49 | 45.67 | |
13 | Journal of Antimicrobial Chemotherapy | journal | 1.744 Q1 | 221 | 510 | 1394 | 12143 | 5713 | 1164 | 4.10 | 23.81 | |
14 | Antiviral Therapy | journal | 1.704 Q1 | 93 | 149 | 371 | 6331 | 1570 | 360 | 4.02 | 42.49 | |
15 | Apoptosis : an international journal on programmed cell death | journal | 1.666 Q1 | 128 | 183 | 408 | 10010 | 1529 | 404 | 3.43 | 54.70 | |
16 | European Neuropsychopharmacology | journal | 1.623 Q1 | 130 | 105 | 261 | 5078 | 1126 | 256 | 4.40 | 48.36 | |
17 | Current Opinion in Drug Discovery and Development | journal | 1.460 Q1 | 85 | 74 | 218 | 3851 | 892 | 202 | 3.85 | 52.04 | |
18 | Expert Opinion on Therapeutic Targets | journal | 1.433 Q1 | 106 | 134 | 227 | 13332 | 756 | 212 | 3.39 | 99.49 | |
19 | Clinical Pharmacokinetics | journal | 1.429 Q1 | 184 | 68 | 241 | 4519 | 1307 | 232 | 4.92 | 66.46 | |
20 | Journal of Psychopharmacology | journal | 1.415 Q1 | 135 | 108 | 345 | 4900 | 1178 | 303 | 3.34 | 45.37 | |
21 | Current Drug Targets: Inflammation and Allergy | journal | 1.399 Q1 | 53 | 0 | 145 | 0 | 580 | 132 | 4.16 | 0.00 | |
22 | Current Drug Metabolism | journal | 1.367 Q1 | 122 | 76 | 150 | 8173 | 850 | 144 | 4.97 | 107.54 | |
23 | Drug Discovery Today | journal | 1.362 Q1 | 215 | 148 | 861 | 7463 | 2772 | 715 | 4.35 | 50.43 | |
24 | Pharmacogenomics Journal | journal | 1.305 Q1 | 95 | 43 | 157 | 2569 | 749 | 146 | 5.40 | 59.74 | |
25 | Drug Safety | journal | 1.235 Q1 | 140 | 108 | 273 | 4980 | 1105 | 248 | 3.80 | 46.11 | |
26 | Inflammation and Allergy - Drug Targets | journal | 1.235 Q1 | 55 | 30 | 32 | 2674 | 92 | 28 | 2.88 | 89.13 | |
27 | Expert Opinion on Investigational Drugs | journal | 1.190 Q1 | 117 | 170 | 411 | 12057 | 1514 | 390 | 3.87 | 70.92 | |
28 | Investigational New Drugs | journal | 1.131 Q1 | 97 | 70 | 183 | 1837 | 575 | 180 | 3.33 | 26.24 | |
29 | PharmacoEconomics | journal | 1.129 Q1 | 118 | 84 | 368 | 3733 | 994 | 318 | 2.45 | 44.44 | |
30 | Clinical Trials | journal | 1.119 Q1 | 74 | 60 | 177 | 1519 | 290 | 162 | 1.66 | 25.32 | |
31 | Expert Opinion on Biological Therapy | journal | 1.092 Q1 | 102 | 165 | 428 | 13835 | 1378 | 425 | 3.12 | 83.85 | |
32 | Reviews in Contemporary Pharmacotherapy | journal | 1.077 Q1 | 18 | 0 | 1 | 0 | 3 | 1 | 0.00 | 0.00 | |
33 | Antiviral Research | journal | 1.064 Q1 | 151 | 114 | 285 | 4393 | 1013 | 283 | 3.83 | 38.54 | |
34 | Cancer Chemotherapy and Pharmacology | journal | 1.053 Q1 | 122 | 193 | 564 | 6080 | 1578 | 560 | 2.83 | 31.50 | |
35 | Current Opinion in Investigational Drugs | journal | 1.033 Q1 | 83 | 113 | 438 | 6943 | 1272 | 406 | 3.04 | 61.44 | |
36 | European Journal of Pharmacology | journal | 1.002 Q2 | 203 | 740 | 2146 | 28348 | 6199 | 2138 | 2.63 | 38.31 | |
37 | Current Opinion in Molecular Therapeutics | journal | 0.985 Q2 | 67 | 72 | 238 | 4448 | 607 | 213 | 2.54 | 61.78 | |
38 | Progress in Medicinal Chemistry | journal | 0.981 Q2 | 38 | 5 | 23 | 777 | 54 | 20 | 2.88 | 155.40 | |
39 | Pharmacogenomics | journal | 0.973 Q2 | 100 | 171 | 302 | 8444 | 1021 | 273 | 3.31 | 49.38 | |
40 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 0.970 Q2 | 57 | 34 | 122 | 1317 | 233 | 111 | 1.95 | 38.74 | |
41 | Expert Opinion on Emerging Drugs | journal | 0.950 Q2 | 54 | 45 | 124 | 4719 | 377 | 124 | 3.05 | 104.87 | |
42 | British Journal of Clinical Pharmacology | journal | 0.934 Q2 | 167 | 230 | 634 | 5435 | 1814 | 522 | 2.65 | 23.63 | |
43 | Journal of Ethnopharmacology | journal | 0.905 Q2 | 231 | 483 | 1192 | 17312 | 3437 | 1178 | 2.62 | 35.84 | |
44 | Clinical and Experimental Pharmacology and Physiology | journal | 0.866 Q2 | 115 | 255 | 563 | 9355 | 1279 | 555 | 2.33 | 36.69 | |
45 | American Journal of PharmacoGenomics | journal | 0.858 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
46 | Naunyn-Schmiedeberg's Archives of Pharmacology | journal | 0.847 Q2 | 99 | 78 | 324 | 4878 | 891 | 315 | 2.35 | 62.54 | |
47 | European Journal of Medicinal Chemistry | journal | 0.842 Q2 | 203 | 160 | 444 | 4962 | 1132 | 444 | 2.41 | 31.01 | |
48 | Planta Medica | journal | 0.839 Q2 | 135 | 236 | 757 | 5684 | 1744 | 747 | 2.02 | 24.08 | |
49 | International Immunopharmacology | journal | 0.836 Q2 | 149 | 214 | 610 | 8640 | 1540 | 595 | 2.36 | 40.37 | |
50 | BMC Pharmacology | journal | 0.821 Q2 | 48 | 18 | 63 | 712 | 152 | 63 | 2.13 | 39.56 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®